-
cdsic.ahrq.gov/sites/default/files/2023-10/TPC%20Pat%20Engage%20Handbook%20Final.pdf
January 01, 2023 - Considerations: Patients who participate in engagement studios should be treated as
consultants who … in the process, not research subjects.106 It is
important that patient engagement in PC CDS is not treated
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary5/visual-impairment-in-children-ages-1-5-screening-2011
January 15, 2011 - received patching treatment (adjusted odds ratio [OR]: 0.39 [95% CI: 0.16-0.92]) but not among those treated … 0.6% (69/1088) vs 1.8% (15/876), RR: 0.35 (95% CI: 0.15-0.86)
Residual amblyopia A among children treated … occlusion: 25% (10/40) vs 8% (3/40); OR: 1.56 (95% CI: 0.62-3.92); residual amblyopia B among children treated
-
hcup-us.ahrq.gov/reports/methods/2016-01.pdf
January 01, 2016 - Stays and Aggregate Hospital Costs in the United States . 8
Inpatient Stays for Select Conditions Treated … Inpatient Stays for Select Conditions Treated near the United States-Mexico Border
The QDR, in collaboration … analysis was limited to community hospitals excluding rehabilitation hospitals and
included all patients treated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/partial-breast-irradiation-disposition-comments.pdf
January 31, 2023 - with IORT but mastectomy-free survival was not different with IORT
vs WBI then how were recurrences treated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
February 23, 2012 - health outcomes such as blood pressure and HbA1c); process
measures (e.g. proportion of patients treated
-
psnet.ahrq.gov/node/72586/psn-pdf
December 23, 2020 - If patients knew they would be treated differently with a DNR order on their charts, would
they consent
-
www.ahrq.gov/news/events/nac/2018-11-nac/nacmtg1118-minutes.html
April 01, 2019 - without drug coverage, pharmacy-reported payments and sources, details on drugs themselves, conditions treated
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/webinars/cahps-creative-strategies-transcript.pdf
April 01, 2019 - So we treated it as a composite. … We treated those four as a measure of patient care experience.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hhrqMCEgbsBMJ_Ppbcp4yJ
January 14, 2025 - Other medical conditions and medications (eg, corticosteroids
or diabetes treated with insulin) may also … ; 9015 participants), corresponding to an ARD of 18
fewer vertebral fractures per 1000 participants treated
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
November 01, 2013 - Continued breast cancer risk reduction in postmenopausal women treated
with raloxifene: 4-year results … Reduction of vertebral fracture risk in postmenopausal women
with osteoporosis treated with raloxifene
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cultural-competence_research-protocol.pdf
July 09, 2014 - Research Protocol: Improving Cultural Competence To Reduce Health Disparities for Priority Populations
Evidence-based Practice Center Systematic Review Protocol
Project Title: Improving…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/QZ-N4vDvgZSsghretDokg7
March 01, 2014 - Ultrasonography Screening for Abdominal Aortic Aneurysms: A
Systematic Evidence Review for the U.S. Preventive Services
Task Force
Janelle M. Guirguis-Blake, MD; Tracy L. Beil, MS; Caitlyn A. Senger, MPH; and Evelyn P. Whitlock, MD, MPH
Background: Long-term follow-up of population-based random-
ized, controlled trial…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-feature-treatment-future_research.pdf
September 23, 2010 - Women with
intracapsular fractures
were significantly more
often treated with
arthroplasty. … Which AO/OTA 31-A fracture patterns
should be treated as unstable fractures?
E.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
October 01, 2016 - placebo showed no difference in the risk for gestational
hypertension or preeclampsia among the DHA-treated … women compared with the placebo-treated women (OR
0.94[0.66, 1.34], I2=0% (n=2,818); pooling studies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
January 01, 2020 - 1
Comparative Effectiveness Review
Number 97
Strategies To Prevent Weight Gain
Among Adults
Executive Summary
Background
Condition
One of the Healthy People 2020 national
objectives is to increase the prevalence
of a healthy weight among adults to
34 percent and to reduce the prevalence
of obesity amon…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0090-fullreport.pdf
July 25, 2016 - Tobacco Use and Help With Quitting Among Adolescents
Tobacco Use and Help With Quitting Among
Adolescents
Section 1. Basic Measure Information
1.A. Measure Name
Tobacco Use and Help With Quitting Among Adolescents
1.B. Measure Number
0090
1.C. Measure Description
Please provide a non-technical description …
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2013_cg_cahps_chartbook.pdf
January 01, 2013 - 2013 CAHPS Clinician & Group Survey Database Chartbook
THE CAHPS DATABASE
2013 CAHPS Clinician & Group
Survey Database
2013 Chartbook: What Patients Say
About Their Health Care Providers
and Medical Practices
AHRQ Contract No.: HHSA290201300003C
Managed and prepared by:
Westat, Rockville, MD
Da…
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/about/2013cliniciangroupchartbook.pdf
July 01, 2014 - 2013 CAHPS Clinician & Group Survey Database Chartbook
THE CAHPS DATABASE
2013 CAHPS Clinician & Group
Survey Database
2013 Chartbook: What Patients Say
About Their Health Care Providers
and Medical Practices
AHRQ Contract No.: HHSA290201300003C
Managed and prepared by:
Westat, Rockville, MD
Da…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
September 25, 2013 - The authors analyzed the potential useful of genotyping and
platelet function testing in patients treated … wide antiplatelet
response variability that is associated with worsened clinical
outcome in patients treated … activity to identify who is, or who is
not going to have an adverse outcome, and therefore should
be treated … issues with the
design of the GRAVITAS study which are related to the fact
that only 48% of patients treated … the
inclusion of studies reporting the correlation of one method
against another method that was treated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
September 01, 2011 - Layout 1
Background
Antipsychotics medications are approved
by the U.S. Food and Drug Administration
(FDA) for treatment of schizophrenia and
bipolar disorder. These medications are
commonly divided into two classes,
reflecting two waves of historical
development: the conventional
antipsychotics and the atypical. T…